Effect of sodium salicylate on insulin rectal absorption in humans. 1994

E Hosny, and O el-Ahmady, and H el-Shattawy, and Nabih A el-M, and H el-Damacy, and S Gamal-el-Deen, and N el-Kabbany
Faculty of Pharmacy, Al-Azhar University, Nasr City, Egypt.

The absorption promoting effect of sodium salicylate (CAS 54-21-7), 200 mg/100-U insulin (CAS 12584-58-6) suppository, was studied in 4 normal volunteers and 15 insulin dependent diabetic patients. Insulin rectal bioavailability was quantitated through the measurement of its hypoglycaemic effect and of its serum levels. A hypoglycaemic effect and a significant rise in serum insulin concentrations were traced at 15 min and maintained for 90 min post administration. The investigated suppositories, thus, proved that sodium salicylate is effective in enhancing the rectal absorption of insulin in humans.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000285 Administration, Rectal The insertion of drugs into the rectum, usually for confused or incompetent patients, like children, infants, and the very old or comatose. Anal Drug Administration,Drug Administration, Rectal,Instillation, Rectal,Rectal Drug Administration,Drug Administration, Anal,Rectal Administration,Administration, Anal Drug,Administration, Rectal Drug,Administrations, Anal Drug,Administrations, Rectal,Administrations, Rectal Drug,Anal Drug Administrations,Drug Administrations, Anal,Drug Administrations, Rectal,Instillations, Rectal,Rectal Administrations,Rectal Drug Administrations,Rectal Instillation,Rectal Instillations

Related Publications

E Hosny, and O el-Ahmady, and H el-Shattawy, and Nabih A el-M, and H el-Damacy, and S Gamal-el-Deen, and N el-Kabbany
June 1984, Chemical & pharmaceutical bulletin,
E Hosny, and O el-Ahmady, and H el-Shattawy, and Nabih A el-M, and H el-Damacy, and S Gamal-el-Deen, and N el-Kabbany
January 1973, Acta physiologica Polonica,
E Hosny, and O el-Ahmady, and H el-Shattawy, and Nabih A el-M, and H el-Damacy, and S Gamal-el-Deen, and N el-Kabbany
September 1988, The Journal of pharmacy and pharmacology,
E Hosny, and O el-Ahmady, and H el-Shattawy, and Nabih A el-M, and H el-Damacy, and S Gamal-el-Deen, and N el-Kabbany
January 1981, Journal of pharmaceutical sciences,
E Hosny, and O el-Ahmady, and H el-Shattawy, and Nabih A el-M, and H el-Damacy, and S Gamal-el-Deen, and N el-Kabbany
June 1971, Journal of pharmaceutical sciences,
E Hosny, and O el-Ahmady, and H el-Shattawy, and Nabih A el-M, and H el-Damacy, and S Gamal-el-Deen, and N el-Kabbany
November 1985, Il Farmaco; edizione pratica,
E Hosny, and O el-Ahmady, and H el-Shattawy, and Nabih A el-M, and H el-Damacy, and S Gamal-el-Deen, and N el-Kabbany
January 1972, Endokrynologia Polska,
E Hosny, and O el-Ahmady, and H el-Shattawy, and Nabih A el-M, and H el-Damacy, and S Gamal-el-Deen, and N el-Kabbany
January 1948, Annales pharmaceutiques francaises,
E Hosny, and O el-Ahmady, and H el-Shattawy, and Nabih A el-M, and H el-Damacy, and S Gamal-el-Deen, and N el-Kabbany
August 1982, Journal of pharmaceutical sciences,
E Hosny, and O el-Ahmady, and H el-Shattawy, and Nabih A el-M, and H el-Damacy, and S Gamal-el-Deen, and N el-Kabbany
May 1989, Drug design and delivery,
Copied contents to your clipboard!